TY - JOUR
T1 - Associations of echocardiographic features with stroke in those without atrial fibrillation
AU - Johansen, Michelle C.
AU - Lin, Michelle
AU - Nazarian, Saman
AU - Gottesman, Rebecca F.
N1 - Funding Information:
M. Johansen and M. Lin report no disclosures relevant to the manuscript. S. Nazarian: consultant to CardioSolv, Siemens, and Biosense Webster, and research grants from Siemens, Biosense Webster, and ImriCor. R. Gottesman: Associate Editor of Neurology®. Go to Neurology.org/N for full disclosures.
Funding Information:
M. Johansen: American Heart Association Mentored Clinical and Population Research Award #16MCPRP30350000, NIH/ICTR (KL2). R. Gottesman: National Institute on Aging (K24 AG052573).
Publisher Copyright:
© 2019 American Academy of Neurology.
PY - 2019/2/26
Y1 - 2019/2/26
N2 - ObjectiveTo determine the associations between transthoracic echocardiogram (TTE) cardiac structure/function measures and cardioembolic stroke (CES) and new-onset atrial fibrillation (AF) in patients without known AF.MethodsInpatients at a single institution (2013-2015) with imaging-confirmed ischemic stroke, no AF, and TTE within the 1st week were included. TTE structure/function variables were abstracted. Stroke subtype (CES vs other) was defined according to Trial of Org 10172 in Acute Stroke Treatment, blinded to TTE results. New AF was defined as any duration of AF on ECG, telemetry, or event monitor. Separate multivariable logistic regression models defined associations between CES or new-onset AF and TTE measures, adjusting for demographic and vascular risk factors.ResultsOf 322 participants (mean age 60 years), 55% were male and 56% African American. In adjusted models (odds ratio, 95% confidence interval), odds of CES increased per 0.1 cm increase in left atrial (LA) systolic diameter (1.06, 1.02-1.11), 1 cm/s in mitral E point velocity (1.03, 1.02-1.05), with presence of mitral valve dysfunction (3.78, 1.42-10.02), and with wall motion abnormality (2.00, 1.13-3.55). As ejection fraction increased (per 10%), odds of CES decreased (0.65, 0.53-0.79). New-onset AF was also associated with increasing LA systolic diameter (1.13, 1.04-1.22).ConclusionsCardiac structural changes independent of AF and detectable on TTE may be on the CES causal pathway. Confirming these results could have implications for future use of TTE and decisions about antithrombotic vs anticoagulant treatment.
AB - ObjectiveTo determine the associations between transthoracic echocardiogram (TTE) cardiac structure/function measures and cardioembolic stroke (CES) and new-onset atrial fibrillation (AF) in patients without known AF.MethodsInpatients at a single institution (2013-2015) with imaging-confirmed ischemic stroke, no AF, and TTE within the 1st week were included. TTE structure/function variables were abstracted. Stroke subtype (CES vs other) was defined according to Trial of Org 10172 in Acute Stroke Treatment, blinded to TTE results. New AF was defined as any duration of AF on ECG, telemetry, or event monitor. Separate multivariable logistic regression models defined associations between CES or new-onset AF and TTE measures, adjusting for demographic and vascular risk factors.ResultsOf 322 participants (mean age 60 years), 55% were male and 56% African American. In adjusted models (odds ratio, 95% confidence interval), odds of CES increased per 0.1 cm increase in left atrial (LA) systolic diameter (1.06, 1.02-1.11), 1 cm/s in mitral E point velocity (1.03, 1.02-1.05), with presence of mitral valve dysfunction (3.78, 1.42-10.02), and with wall motion abnormality (2.00, 1.13-3.55). As ejection fraction increased (per 10%), odds of CES decreased (0.65, 0.53-0.79). New-onset AF was also associated with increasing LA systolic diameter (1.13, 1.04-1.22).ConclusionsCardiac structural changes independent of AF and detectable on TTE may be on the CES causal pathway. Confirming these results could have implications for future use of TTE and decisions about antithrombotic vs anticoagulant treatment.
UR - http://www.scopus.com/inward/record.url?scp=85062173315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062173315&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000007002
DO - 10.1212/WNL.0000000000007002
M3 - Article
C2 - 30674593
AN - SCOPUS:85062173315
SN - 0028-3878
VL - 92
SP - E924-E932
JO - Neurology
JF - Neurology
IS - 9
ER -